Long-Chain Fatty Acid Oxidation Disorders In-Clinic Disease Monitoring Program
NCT04632953 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 150
Last updated 2026-03-06
Summary
The primary objective of this study is to assess the long-term safety, including pregnancy, infant, and lactation outcomes, of patients with LC-FAOD who are enrolled in the DMP.
Conditions
- Long-chain Fatty Acid Oxidation Disorders (LC-FAOD)
Interventions
- OTHER
-
No Intervention
No Intervention
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
Medical Director · Ultragenyx Pharmaceutical Inc
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2021-11-30
- Primary Completion
- 2035-12-31
- Completion
- 2035-12-31
- FDA Drug
- Yes
Countries
- United States
- Canada
Study Locations
More Related Trials
-
Pretreatment of Patients Expecting Bariatric Surgery With the GLP-1 Analogon Liraglutid
NCT02417103 ·Status: TERMINATED ·Phase: PHASE3
-
Microbes and Bariatric Surgery
NCT01130207 ·Status: COMPLETED
-
GLP1 Fasting Status and Gastric Retention Using Gastric Ultrasound
NCT07251803 ·Status: RECRUITING
-
ATX-101 Abdominoplasty
NCT00835952 ·Status: COMPLETED ·Phase: PHASE1
-
Feeding Trial in the Obese Critical Care Population
NCT01357200 ·Status: COMPLETED
-
Safety Evaluation of the LGL102 in Obese Subjects Treated With OMS102
NCT01539850 ·Status: COMPLETED ·Phase: NA
-
Medical Supervised Duodenal-Enteral Feeding Treatment
NCT03542864 ·Status: COMPLETED ·Phase: NA
-
The AUDACITY Study (AllUrion Device in Adults With Clinical ObesITY)
NCT05368259 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Routine Validation and Reproducibility Testing of Laboratory Assays and Research Techniques Used for Endocrine, Cardiometabolic, and Musculoskeletal Disorder Research (VALD)
NCT07083557 ·Status: RECRUITING
-
Safety and Efficacy Evaluation of UltheraTM in Treatment of Baggy Eyelid
NCT01693055 ·Status: COMPLETED ·Phase: NA
-
Examination of Circumferential Reduction
NCT04451824 ·Status: COMPLETED ·Phase: NA
-
The Volumetric Analysis of Fat Grafting
NCT03544593 ·Status: UNKNOWN ·Phase: NA
-
Gastric Ultrasound in Patients Who Have Undergone Bariatric Surgery
NCT07310875 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Evaluation of Procedural Analgesia for Liposonix Treatment
NCT01993238 ·Status: COMPLETED ·Phase: NA
-
Tissue and Plasma Pharmacokinetics of Cefazolin in Antibiotic Prophylaxis in Bariatric Surgery
NCT01537380 ·Status: COMPLETED ·Phase: PHASE4
-
A Prospective Multicenter Post Approval Study of the ReShape™ Integrated Dual Balloon System in Obese Subjects
NCT02927665 ·Status: UNKNOWN
-
Effects of Ultrasound Cavitation Focused on Located Adiposity
NCT02539043 ·Status: COMPLETED ·Phase: NA
-
Fat Reduction in the Flanks Area vs. Control
NCT02465775 ·Status: UNKNOWN ·Phase: NA
-
A Cholesterol Lowering Therapy of Focused Power Ultrasound Mediated Perirenal Fat Ablation
NCT04223557 ·Status: COMPLETED ·Phase: NA
-
Clinical Study Protocol for the Assessment of Safety and Efficacy of the BARICLIP®
NCT06338709 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Gastric Electrical Stimulation (GES) for the Treatment of Obesity
NCT01823705 ·Status: COMPLETED ·Phase: NA
-
Open-label, Prospective Evaluation of the Ulthera® System for Lifting Submental (Under the Chin) and Neck Tissue in Chinese Patients
NCT03351335 ·Status: COMPLETED ·Phase: NA
-
Effects of Beginning a GLP1-Agonist Therapy on Residual Gastric Content and Gastric Emptying
NCT06659159 ·Status: NOT_YET_RECRUITING
-
Using Point-of-Care-Ultrasound (POCUS) to Assess Gastric Contents Among Fasting Pre-operative Patients Taking GLP-1 Agonists.
NCT06038734 ·Status: COMPLETED
-
Clinical Study to Evaluate the Safety and Efficacy of the UltraShape Device for Non-Invasive Abdominal Fat Reduction
NCT02700152 ·Status: UNKNOWN ·Phase: NA